Labcorp Return on Tangible Equity 2010-2024 | LH

Current and historical return on tangible equity values for Labcorp (LH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Labcorp Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $0.44B $-1.85B -26.12%
2024-06-30 $0.45B $-1.55B -27.45%
2024-03-31 $0.43B $-1.65B -31.22%
2023-12-31 $0.42B $-1.61B -29.95%
2023-09-30 $0.66B $-1.73B -84.66%
2023-06-30 $0.83B $-0.55B -100.06%
2023-03-31 $1.00B $-1.69B -92.07%
2022-12-31 $1.28B $0.85B -125.52%
2022-09-30 $1.76B $-1.93B -110.69%
2022-06-30 $1.99B $-1.58B -143.42%
2022-03-31 $2.10B $-1.42B -160.60%
2021-12-31 $2.38B $-1.42B -177.92%
2021-09-30 $2.76B $-1.14B -178.22%
2021-06-30 $2.88B $-1.25B -137.75%
2021-03-31 $2.64B $-1.53B -95.67%
2020-12-31 $1.56B $-2.28B -45.13%
2020-09-30 $0.85B $-3.30B -21.33%
2020-06-30 $0.36B $-3.95B -8.46%
2020-03-31 $0.32B $-4.27B -7.16%
2019-12-31 $0.82B $-4.33B -18.50%
2019-09-30 $0.76B $-4.61B -16.99%
2019-06-30 $0.85B $-4.72B -19.75%
2019-03-31 $0.90B $-4.16B -21.11%
2018-12-31 $0.88B $-4.30B -19.90%
2018-09-30 $1.41B $-4.11B -31.02%
2018-06-30 $1.27B $-4.44B -25.67%
2018-03-31 $1.22B $-4.93B -24.74%
2017-12-31 $1.23B $-4.76B -25.74%
2017-09-30 $0.70B $-5.62B -15.11%
2017-06-30 $0.71B $-4.39B -16.42%
2017-03-31 $0.73B $-4.32B -16.97%
2016-12-31 $0.71B $-4.32B -16.37%
2016-09-30 $0.66B $-4.32B -14.90%
2016-06-30 $0.63B $-4.26B -14.02%
2016-03-31 $0.60B $-4.50B -12.74%
2015-12-31 $0.44B $-4.58B -8.90%
2015-09-30 $0.45B $-4.72B -10.63%
2015-06-30 $0.43B $-5.01B -12.36%
2015-03-31 $0.40B $-5.37B -14.76%
2014-12-31 $0.51B $-1.76B -26.88%
2014-09-30 $0.52B $-1.79B -26.01%
2014-06-30 $0.53B $-1.96B -25.77%
2014-03-31 $0.54B $-2.10B -26.41%
2013-12-31 $0.57B $-2.10B -29.30%
2013-09-30 $0.57B $-2.03B -29.96%
2013-06-30 $0.57B $-1.93B -30.75%
2013-03-31 $0.57B $-1.76B -32.01%
2012-12-31 $0.58B $-1.85B -33.15%
2012-09-30 $0.60B $-1.83B -34.26%
2012-06-30 $0.58B $-1.65B -34.15%
2012-03-31 $0.55B $-1.70B -31.98%
2011-12-31 $0.52B $-1.80B -29.16%
2011-09-30 $0.52B $-1.69B -28.95%
2011-06-30 $0.52B $-1.74B -31.70%
2011-03-31 $0.55B $-1.89B -36.82%
2010-12-31 $0.56B $-1.81B -42.56%
2010-09-30 $0.57B $-1.15B -49.80%
2010-06-30 $0.56B $-1.16B -48.79%
2010-03-31 $0.54B $-1.14B -48.94%
2009-12-31 $0.54B $-1.13B -48.69%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.953B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.221B 20.52
Becton Dickinson (BDX) United States $68.842B 18.04
Cardinal Health (CAH) United States $30.559B 16.57
West Pharmaceutical Services (WST) United States $24.359B 49.75
Cooper (COO) United States $18.615B 25.21
Align Technology (ALGN) United States $16.739B 32.03
Henry Schein (HSIC) United States $9.129B 17.39
Merit Medical Systems (MMSI) United States $5.997B 30.62
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
Patterson (PDCO) United States $2.729B 14.57
CONMED (CNMD) United States $2.091B 17.45
STAAR Surgical (STAA) United States $1.098B 40.53
Lifevantage (LFVN) United States $0.317B 42.18
Pro-Dex (PDEX) United States $0.145B 28.80